Cherry W. Jackson

706 total citations
21 papers, 347 citations indexed

About

Cherry W. Jackson is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, Cherry W. Jackson has authored 21 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 5 papers in Clinical Psychology and 4 papers in Pharmacology. Recurrent topics in Cherry W. Jackson's work include Obsessive-Compulsive Spectrum Disorders (5 papers), Schizophrenia research and treatment (4 papers) and Bipolar Disorder and Treatment (3 papers). Cherry W. Jackson is often cited by papers focused on Obsessive-Compulsive Spectrum Disorders (5 papers), Schizophrenia research and treatment (4 papers) and Bipolar Disorder and Treatment (3 papers). Cherry W. Jackson collaborates with scholars based in United States. Cherry W. Jackson's co-authors include John S. Markowitz, Joseph F. Lipinski, Gopalan Sethuraman, Floyd R. Sallee, Amy Sheehan, Marshall E. Cates, Raymond A. Lorenz, William H. Carson, Jacqueline Feldman and Thomas W. Woolley and has published in prestigious journals such as Biological Psychiatry, Movement Disorders and Journal of Clinical Psychopharmacology.

In The Last Decade

Cherry W. Jackson

20 papers receiving 312 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cherry W. Jackson United States	10	137	123	69	47	36	21	347
J. Caudle United States	13	234 1.7×	91 0.7×	124 1.8×	51 1.1×	25 0.7×	28	698
Koen P. Grootens Netherlands	13	249 1.8×	123 1.0×	80 1.2×	37 0.8×	13 0.4×	37	460
Ilya Reznik Israel	13	325 2.4×	153 1.2×	121 1.8×	56 1.2×	21 0.6×	32	569
J.H. Jhoo South Korea	13	243 1.8×	62 0.5×	76 1.1×	26 0.6×	16 0.4×	22	531
Doron Mazeh Israel	16	326 2.4×	86 0.7×	41 0.6×	50 1.1×	34 0.9×	21	544
Eva M. Sheridan United States	9	324 2.4×	152 1.2×	65 0.9×	26 0.6×	13 0.4×	12	444
Caroline Lücke Germany	12	147 1.1×	94 0.8×	82 1.2×	23 0.5×	9 0.3×	23	347
Dale R. Grothe United States	10	264 1.9×	97 0.8×	56 0.8×	30 0.6×	23 0.6×	19	456
B. Krumm Germany	12	282 2.1×	85 0.7×	28 0.4×	28 0.6×	34 0.9×	28	480
Chia-Hung Tang Taiwan	7	212 1.5×	58 0.5×	94 1.4×	28 0.6×	53 1.5×	14	434

Countries citing papers authored by Cherry W. Jackson

Since Specialization

Citations

This map shows the geographic impact of Cherry W. Jackson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cherry W. Jackson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cherry W. Jackson more than expected).

Fields of papers citing papers by Cherry W. Jackson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cherry W. Jackson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cherry W. Jackson. The network helps show where Cherry W. Jackson may publish in the future.

Co-authorship network of co-authors of Cherry W. Jackson

This figure shows the co-authorship network connecting the top 25 collaborators of Cherry W. Jackson. A scholar is included among the top collaborators of Cherry W. Jackson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cherry W. Jackson. Cherry W. Jackson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Qian, Jingjing, et al.. (2025). Post-marketing safety of antiseizure medications: Focus on serious adverse effects including drug reaction with eosinophilia and systemic symptoms (DRESS). Seizure. 125. 37–43. 1 indexed citations

Fargason, Rachel E., Karen L. Gamble, Kristin T. Avis, et al.. (2025). Ramelteon for Insomnia Related to Attention-Deficit/Hyperactivity Disorder (ADHD). Psychopharmacology Bulletin. 44(2). 32–53.

Jackson, Cherry W., et al.. (2022). Paliperidone-Associated Sialorrhea. Journal of Clinical Psychopharmacology. 42(5). 480–484. 2 indexed citations

Jackson, Cherry W., et al.. (2020). ASHP Therapeutic Position Statement on the Use of Antipsychotic Medications in the Treatment of Adults with Schizophrenia and Schizoaffective Disorder. American Journal of Health-System Pharmacy. 77(24). 2114–2132. 7 indexed citations

Andrus, Miranda, Kristi W. Kelley, Heather P. Whitley, et al.. (2018). Development and Validation of a Rubric to Evaluate Diabetes SOAP Note Writing in APPE. American Journal of Pharmaceutical Education. 82(9). 6725–6725. 14 indexed citations

Andrus, Miranda, et al.. (2018). Ambulatory care preceptors’ perceptions on SOAP note writing in advanced pharmacy practice experiences (APPEs). Currents in Pharmacy Teaching and Learning. 10(12). 1574–1578. 6 indexed citations

Jackson, Cherry W., Marshall E. Cates, & Raymond A. Lorenz. (2010). Pharmacotherapy of Eating Disorders. Nutrition in Clinical Practice. 25(2). 143–159. 15 indexed citations

Lorenz, Raymond A., et al.. (2010). Adjunctive Use of Atypical Antipsychotics for Treatment‐Resistant Generalized Anxiety Disorder. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 30(9). 942–951. 23 indexed citations

Cates, Marshall E., et al.. (2009). Metabolic Consequences of Using Low-Dose Quetiapine for Insomnia in Psychiatric Patients. Community Mental Health Journal. 45(4). 251–254. 45 indexed citations

10.

Jackson, Cherry W. & Kenneth Jackson. (2007). Comorbid Depression in Adult Oncology. Journal of Pharmacy Practice. 20(5). 360–367. 4 indexed citations

11.

Jackson, Cherry W., et al.. (2007). Evidence-based review of the black-box warning for droperidol. American Journal of Health-System Pharmacy. 64(11). 1174–1186. 48 indexed citations

12.

Markowitz, John S., et al.. (1999). Is Valproate Pharmacotherapy Associated with Polycystic Ovaries?. Annals of Pharmacotherapy. 33(11). 1211–1216. 21 indexed citations

13.

Markowitz, John S., William H. Carson, & Cherry W. Jackson. (1999). Possible dihydroepiandrosterone-induced mania. Biological Psychiatry. 45(2). 241–242. 36 indexed citations

14.

Jackson, Cherry W.. (1998). Antidepressants in the Treatment of Chronic Pain. Journal of Pharmacy Practice. 11(5). 388–393. 8 indexed citations

15.

Lipinski, Joseph F., Floyd R. Sallee, Cherry W. Jackson, & Gopalan Sethuraman. (1997). Dopamine agonist treatment of tourette disorder in children: Results of an open‐label trial of pergolide. Movement Disorders. 12(3). 402–407. 68 indexed citations

16.

Jackson, Cherry W., et al.. (1996). Zolpidem for the treatment of agitation in elderly demented patients.. PubMed. 57(8). 372–3. 5 indexed citations

17.

Jackson, Cherry W.. (1995). Obsessive-Compulsive Disorder in Elderly Patients. Drugs & Aging. 7(6). 438–448. 5 indexed citations

18.

Jackson, Cherry W., John S. Markowitz, & Timothy D. Brewerton. (1995). Delirium Associated with Clozapine and Benzodiazepine Combinations. Annals of Clinical Psychiatry. 7(3). 139–141. 23 indexed citations

19.

Jackson, Cherry W., W. Alexander Morton, & R. Bruce Lydiard. (1994). Pharmacologic Management of Obsessive- Compulsive Disorder. Southern Medical Journal. 87(3). 310–321. 12 indexed citations

20.

Lydiard, R. Bruce & Cherry W. Jackson. (1991). Reply to Dr. Friedman. Journal of Clinical Psychopharmacology. 11(6). 395–395. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact